Submitted by web@researchtop... on Fri, 04/05/2013 - 12:17
Submitted by web@researchtop... on Fri, 04/05/2013 - 12:10
Submitted by web@researchtop... on Fri, 04/05/2013 - 12:05
Submitted by web@researchtop... on Thu, 04/04/2013 - 15:08
Submitted by web@researchtop... on Thu, 03/07/2013 - 12:32
COMFORT-I: Updated Overall Survival Analysis by JAK2V617F Mutation Status
Back to 5MJC main page
Submitted by web@researchtop... on Mon, 03/04/2013 - 13:12
Submitted by web@researchtop... on Mon, 03/04/2013 - 12:18
Submitted by web@researchtop... on Tue, 02/26/2013 - 16:27
Ibrutinib/Rituximab: Computed Tomography at 3-6 Months (n = 31)
Back to 5MJC main page
Submitted by mphilemon@resea... on Tue, 02/19/2013 - 16:22
Submitted by mphilemon@resea... on Tue, 02/19/2013 - 14:42
Submitted by mphilemon@resea... on Thu, 02/14/2013 - 15:53
Submitted by web@researchtop... on Wed, 01/30/2013 - 15:56
Ongoing Clinical Trials Exhibit
1. CALGB-140503
A Phase III randomized trial of lobectomy versus sublobar resection for small (≤2 cm) peripheral NSCLC
2. ACOSOG-Z4099
Surgery with or without internal radiation therapy compared to stereotactic body radiation therapy in treating patients with high-risk Stage I NSCLC
Submitted by web@researchtop... on Wed, 01/16/2013 - 17:14
Submitted by web@researchtop... on Wed, 01/16/2013 - 17:13
Submitted by web@researchtop... on Wed, 01/16/2013 - 17:11